Investors & Media

Corporate Profile

Millendo Therapeutics is a biopharmaceutical company primarily focused on developing novel treatments for endocrine diseases. We create distinct and transformative treatments for endocrine diseases where there is a significant unmet medical need. We are currently advancing MLE-301 for the treatment of vasomotor symptoms (VMS) associated with menopause.

Corporate Presentation

December 2020 Investor Presentation

Stock Quote

Data Provided by Refinitiv. Minimum 15 minutes delayed.

Upcoming Events

There are no upcoming events available at this time.